Inhibition of invariant chain expression in dendritic cells presenting endogenous antigens stimulates CD4+ T-cell responses and tumor immunity

Yangbing Zhao, David Boczkowski, Smita K. Nair, Eli Gilboa

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Induction of potent and sustained antiviral or antitumor immunity is dependent on the efficient activation of CD8+ and CD4+ T cells. While dendritic cells constitute a powerful platform for stimulating cellular immunity, presentation of endogenous antigens by dendritic cells transfected with nucleic acid-encoded antigens favors the stimulation of CD8+ T cells over that of CD4+ T cells. A short incubation of mRNA-transfected dendritic cells with antisense oligonucleotides directed against the invariant chain enhances the presentation of mRNA-encoded class II epitopes and activation of CD4+ T-cell responses in vitro and in vivo. Immunization of mice with the antisense oligonucleotide-treated dendritic cells stimulates a more potent and longer lasting CD8+ cytotoxic T-cell (CTL) response and enhances the antitumor efficacy of dendritic cell-based tumor vaccination protocols. Transient inhibition of invariant chain expression represents a simple and general method to enhance the stimulation of CD4+ T-cell responses from endogenous antigens.

Original languageEnglish
Pages (from-to)4137-4142
Number of pages6
JournalBlood
Volume102
Issue number12
DOIs
StatePublished - Dec 1 2003
Externally publishedYes

Fingerprint

CD4 Antigens
T-cells
Dendritic Cells
Tumors
Immunity
T-Lymphocytes
Neoplasms
Antisense Oligonucleotides
Antigens
Chemical activation
Immunization
Messenger RNA
Antigen Presentation
Cellular Immunity
Nucleic Acids
Antiviral Agents
invariant chain
Epitopes
Vaccination

ASJC Scopus subject areas

  • Hematology

Cite this

Inhibition of invariant chain expression in dendritic cells presenting endogenous antigens stimulates CD4+ T-cell responses and tumor immunity. / Zhao, Yangbing; Boczkowski, David; Nair, Smita K.; Gilboa, Eli.

In: Blood, Vol. 102, No. 12, 01.12.2003, p. 4137-4142.

Research output: Contribution to journalArticle

@article{5ee732daa06d406bba2439a426ca7f22,
title = "Inhibition of invariant chain expression in dendritic cells presenting endogenous antigens stimulates CD4+ T-cell responses and tumor immunity",
abstract = "Induction of potent and sustained antiviral or antitumor immunity is dependent on the efficient activation of CD8+ and CD4+ T cells. While dendritic cells constitute a powerful platform for stimulating cellular immunity, presentation of endogenous antigens by dendritic cells transfected with nucleic acid-encoded antigens favors the stimulation of CD8+ T cells over that of CD4+ T cells. A short incubation of mRNA-transfected dendritic cells with antisense oligonucleotides directed against the invariant chain enhances the presentation of mRNA-encoded class II epitopes and activation of CD4+ T-cell responses in vitro and in vivo. Immunization of mice with the antisense oligonucleotide-treated dendritic cells stimulates a more potent and longer lasting CD8+ cytotoxic T-cell (CTL) response and enhances the antitumor efficacy of dendritic cell-based tumor vaccination protocols. Transient inhibition of invariant chain expression represents a simple and general method to enhance the stimulation of CD4+ T-cell responses from endogenous antigens.",
author = "Yangbing Zhao and David Boczkowski and Nair, {Smita K.} and Eli Gilboa",
year = "2003",
month = "12",
day = "1",
doi = "10.1182/blood-2003-06-1867",
language = "English",
volume = "102",
pages = "4137--4142",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "12",

}

TY - JOUR

T1 - Inhibition of invariant chain expression in dendritic cells presenting endogenous antigens stimulates CD4+ T-cell responses and tumor immunity

AU - Zhao, Yangbing

AU - Boczkowski, David

AU - Nair, Smita K.

AU - Gilboa, Eli

PY - 2003/12/1

Y1 - 2003/12/1

N2 - Induction of potent and sustained antiviral or antitumor immunity is dependent on the efficient activation of CD8+ and CD4+ T cells. While dendritic cells constitute a powerful platform for stimulating cellular immunity, presentation of endogenous antigens by dendritic cells transfected with nucleic acid-encoded antigens favors the stimulation of CD8+ T cells over that of CD4+ T cells. A short incubation of mRNA-transfected dendritic cells with antisense oligonucleotides directed against the invariant chain enhances the presentation of mRNA-encoded class II epitopes and activation of CD4+ T-cell responses in vitro and in vivo. Immunization of mice with the antisense oligonucleotide-treated dendritic cells stimulates a more potent and longer lasting CD8+ cytotoxic T-cell (CTL) response and enhances the antitumor efficacy of dendritic cell-based tumor vaccination protocols. Transient inhibition of invariant chain expression represents a simple and general method to enhance the stimulation of CD4+ T-cell responses from endogenous antigens.

AB - Induction of potent and sustained antiviral or antitumor immunity is dependent on the efficient activation of CD8+ and CD4+ T cells. While dendritic cells constitute a powerful platform for stimulating cellular immunity, presentation of endogenous antigens by dendritic cells transfected with nucleic acid-encoded antigens favors the stimulation of CD8+ T cells over that of CD4+ T cells. A short incubation of mRNA-transfected dendritic cells with antisense oligonucleotides directed against the invariant chain enhances the presentation of mRNA-encoded class II epitopes and activation of CD4+ T-cell responses in vitro and in vivo. Immunization of mice with the antisense oligonucleotide-treated dendritic cells stimulates a more potent and longer lasting CD8+ cytotoxic T-cell (CTL) response and enhances the antitumor efficacy of dendritic cell-based tumor vaccination protocols. Transient inhibition of invariant chain expression represents a simple and general method to enhance the stimulation of CD4+ T-cell responses from endogenous antigens.

UR - http://www.scopus.com/inward/record.url?scp=0344826053&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0344826053&partnerID=8YFLogxK

U2 - 10.1182/blood-2003-06-1867

DO - 10.1182/blood-2003-06-1867

M3 - Article

C2 - 12920018

AN - SCOPUS:0344826053

VL - 102

SP - 4137

EP - 4142

JO - Blood

JF - Blood

SN - 0006-4971

IS - 12

ER -